Share on

APAC Vascular Guidewires Market Research Report – Segmented By Product, Coating Type, End-User and Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC) - Industry Analysis on Size, Share, Trends COVID-19 Impact and Growth Forecast (2023 to 2028)

Published: March, 2023
ID: 6681
Pages: 145
Formats: report pdf report excel report power bi report ppt

APAC Vascular Guidewires Market Size (2023 to 2028)

The size of the Vascular Guidewires Market in the Asia Pacific is estimated to hike at a brisk pace from 2023 to 2028.

The Asia Pacific Vascular guidewires market is being propelled by factors such as a rise in the incidence of coronary diseases, an increase in the elderly population, a high demand for less invasive treatments, and technical advances in guidewires. Coronary guidewires are specialized devices used to introduce and place balloon catheters and other devices into the coronary system during angioplasty operations. With the growing number of individuals suffering from heart disease, new devices are being developed all the time to give doctors and patients the greatest surgical experience possible. In addition, endoscopic methods are being used by physicians to see and remove lesions that were traditionally treated with big, open operations, which are driving the need for guidewires in the region. Government-implemented favorable medical reimbursement policies are projected to provide substantial possibilities for market expansion throughout the forecast period. In this region, strict reimbursement rules are anticipated to promote the use of guidewires in cardiac surgical operations, which would eventually boost the market for coronary guidewires.

As the government steps to grow the treatment device market, several important firms are investing and expanding their businesses in Japan. These initiatives will help the Asia Pacific vascular guidewires market to develop in the future. As a result, the use of nitinol in vascular guidewires is becoming more common. During the forecast period, the market is likely to benefit from many growth prospects in the Asia Pacific. Due to the fast rise in medical tourism, the advent of automated IVF processes, and the progressive move toward minimally invasive or non-invasive IVF treatments in the area, the market in the Asia Pacific is expected to grow. With manufacturers focusing on developing technologically improved guidewires and the growing death rate from heart diseases, it is expected that demand for coronary guidewires will increase in the future, and the market will expand rapidly.

The lack of a variety of new products on the market impacts price, restricting the expansion of the vascular guidewires industry. The APAC vascular guidewires market is being hampered by the availability of efficient conventional therapeutic options. Manufacturers are challenged as the complexity of producing vascular guidewires expands, as does the high capital cost needed.

This research report on the APAC vascular guidewires market has been segmented and sub-segmented into the following categories.

By Product

  • Coronary Guidewires
  • Peripheral Guidewires

By Coating Type

  • Coated
    • Hydrophobic Coatings
    • Non-Hydrophobic Coatings
  • Non-Coated

By End-User

  • Hospitals
  • Ambulatory Surgical Centers

By Country:

  • India
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Thailand
  • Malaysia
  • Vietnam
  • Philippines
  • Indonesia
  • Singapore
  • Rest of APAC

Based on geography, The Asia-Pacific market is anticipated to expand at the fastest CAGR during the forecast period, owing to a high incidence of chronic illnesses and an increase in mortality rate, owing to individuals adopting a western lifestyle and changing their eating habits. Furthermore, a large population base, rising disposable income, the prevalence of unmet medical requirements, and an increase in medical tourism in the area all contribute to the growth of the vascular guidewires market. In addition, increased reimbursements for guidewires in this region and an increase in patient desire for less invasive surgical treatments are driving guidewire demand growth in the area. Due to rising healthcare expenditure and increased measures in Asia Pacific nations to promote guidewires during minimally invasive operations, the Asia Pacific region is projected to develop in the coming years.

KEY MARKET PLAYERS:

Major manufacturers dominating the Asia pacific vascular guidewires market are Abbott Laboratories, Terumo Corporation, B. Braun Melsungen AG, Medtronic plc, Biotronik SE & Co. KG, Cook Medical, Inc., Boston Scientific Corporation, Cardinal Health, Inc., C. R. Bard, Inc., and The Spectranetics Corporation.

Please wait. . . . Your request is being processed

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000

Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM

Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!

REACH OUT TO US

Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us: [email protected]

Click for Request Sample